These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7241114)

  • 1. Effects of apomorphine on behavioural activity and brain catecholamine synthesis in normal and L-triiodothyronine-treated rats.
    Rastogi RB; Singhal RL; Lapierre YD
    J Neural Transm; 1981; 50(2-4):139-48. PubMed ID: 7241114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of neonatal and adult hyperthyroidism on behavior and biosynthetic capacity for norepinephrine, dopamine and 5-hydroxytryptamine in rat brain.
    Rastogi RB; Singhal RL
    J Pharmacol Exp Ther; 1976 Sep; 198(3):609-18. PubMed ID: 978462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that chronic apomorphine treatment enhances 5-hydroxytryptamine metabolism in brains of normal and neonatally hyperthyroid rats.
    Rastogi RB; Singhal RL
    Neuroendocrinology; 1979; 29(6):399-405. PubMed ID: 574927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lithium: modification of behavioral activity and brain biogenic amines in developing hyperthyroid rats.
    Rastoge RB; Singhal RL
    J Pharmacol Exp Ther; 1977 Apr; 201(1):92-102. PubMed ID: 850149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioural and biochemical alterations in the function of dopamine receptors following repeated administration of L-DOPA to rats.
    Hall MD; Cooper DR; Fleminger S; Rupniak NM; Jenner P; Marsden CD
    Neuropharmacology; 1984 May; 23(5):545-53. PubMed ID: 6539859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lithium suppresses elevated behavioural activity and brain catecholamines in developing hyperthyroid rats.
    Rastogi RB; Singhal RL
    Can J Physiol Pharmacol; 1977 Jun; 55(3):490-5. PubMed ID: 18270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioural and biochemical alterations following haloperidol treatment and withdrawal: the animal model of tardive dyskinesia reexamined.
    Rastogi SK; Rastogi RB; Singhal RL; Lapierre YD
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(2-3):153-64. PubMed ID: 6137027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated administration of triiodothyronine (T3) to rats enhances nigrostriatal and mesolimbic dopaminergic behavioural responses.
    Heal DJ; Atterwill CK
    Neuropharmacology; 1982 Feb; 21(2):159-62. PubMed ID: 7063110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurochemical correlates of behavioral sensitization following repeated apomorphine treatment: assessment of the role of D1 dopamine receptor stimulation.
    Rowlett JK; Mattingly BA; Bardo MT
    Synapse; 1993 Jun; 14(2):160-8. PubMed ID: 8332946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential responses in central dopaminergic activity induced by apomorphine in IPL nude rat.
    Estrella CR; Bregonzio C; Cabrera RJ
    Behav Brain Res; 2002 Jul; 133(2):143-8. PubMed ID: 12110447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurochemical and behavioral effects of acute and chronic treatment with apomorphine in rats.
    Rowlett JK; Mattingly BA; Bardo MT
    Neuropharmacology; 1991 Feb; 30(2):191-7. PubMed ID: 1903190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Facilitation of a stereotyped motor behavior (climbing behavior) by previous stimulation of dopaminergic receptors: hyposensitivity of autoreceptors?].
    Costentin J; Marçais H; Protais P; Baudry M; Martres MP; Schwartz JC
    C R Acad Hebd Seances Acad Sci D; 1977 Jan; 284(2):143-6. PubMed ID: 402241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of apomorphine enantiomers and of lisuride on 3,4-dihydroxyphenylalanine production in striatal synaptosomes.
    Bräutigam M; Kittner B; Laschinski G
    Mol Pharmacol; 1985 Dec; 28(6):515-20. PubMed ID: 3935908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of short- and long-term treatment with neuroleptics on behavioural activity as well as dopamine turnover in striatum.
    Rastogi RB; Singhal RL; Lapierre YD
    Gen Pharmacol; 1982; 13(1):35-40. PubMed ID: 6120880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subsensitivity of striatal and mesolimbic dopamine target cells after repeated treatment with apomorphine dipivaloyl ester.
    Scatton B; Worms P
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Jul; 303(3):271-8. PubMed ID: 567284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated apomorphine treatment causes behavioural supersensitivity and dopamine D2 receptor hyposensitivity.
    Bevan P
    Neurosci Lett; 1983 Feb; 35(2):185-9. PubMed ID: 6222273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catecholamine receptor agonists: effects on motor activity and rate of tyrosine hydroxylation in mouse brain.
    Strömbom U
    Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(2):167-76. PubMed ID: 181681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
    Breese GR; Napier TC; Mueller RA
    J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal hyperthyroidism: alterations in behavioural activity and the metabolism of brain norepinephrine and dopamine.
    Rastogi RB; Singhal RL
    Life Sci; 1976 Apr; 18(8):851-7. PubMed ID: 5639
    [No Abstract]   [Full Text] [Related]  

  • 20. Behavioural and biochemical effects in the adult rat after prolonged postnatal administration of clozapine.
    Cuomo V; Cagiano R; Mocchetti I; Coen E; Cattabeni F; Racagni G
    Psychopharmacology (Berl); 1983; 81(3):239-43. PubMed ID: 6417713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.